Related references
Note: Only part of the references are listed.MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients
Qing Yi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Vaccines for lymphomas: Idiotype vaccines and beyond
Roch Houot et al.
BLOOD REVIEWS (2009)
Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth
Sungyoul Hong et al.
CANCER RESEARCH (2008)
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
Antonio Curti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma
Jianfei Qian et al.
BLOOD (2007)
Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma
Siqing Wang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Preclinical development of hybrid cell vaccines for multiple myeloma
Renata Walewska et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Targeting heat shock proteins for immunotherapy in multiple myeloma: Generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
JF Qian et al.
CLINICAL CANCER RESEARCH (2005)
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
I Hus et al.
LEUKEMIA (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
N Raje et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
T Maier et al.
BLOOD (2003)
Optimizing dendritic cell-based immunotherapy in multiple myeloma
Q Yi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy
YJ Wen et al.
BLOOD (2002)
Active immunization against cancer with dendritic cells: The near future
RM Steinman et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells
YJ Wen et al.
BLOOD (2001)
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
S Titzer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
A Liso et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
